Streetbeat News

Earnings

MRTX

Mirati Therapeutics reported Q2 earnings per share (EPS) of $(3.04), beating the estimate of $(3.23) by 5.88%. However, the company's sales of $13.69M missed the estimate of $13.92M by 1.65%. The EPS is a 4.4% increase from last year, while the sales represent a 155.32% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 8:03 pm

HALO

Halozyme Therapeutics reported Q2 earnings of $0.74 per share, beating the analyst consensus estimate of $0.63 by 17.46%. This is a 39.62% increase from the same period last year. The company also reported quarterly sales of $221.00 million, beating the analyst consensus estimate of $199.32 million by 10.88%. This is a 45.05% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:03 pm

MVIS

Microvision reported Q2 losses of $(0.12) per share, missing the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent decrease over losses from the same period last year. The company also reported quarterly sales of $329.00 thousand, missing the analyst consensus estimate of $800.00 thousand by 58.88 percent. However, this is a 4.78 percent increase over sales from the same period last year.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 8:03 pm

GO

Grocery Outlet Holding (NASDAQ:GO) reported Q2 earnings of $0.32 per share, beating the analyst consensus estimate of $0.26 by 23.08%. The company also reported quarterly sales of $1.01 billion, surpassing the analyst consensus estimate of $972.16 million by 3.89%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:02 pm

RLMD

Relmada Therapeutics reported Q2 losses of $(0.84) per share, beating the analyst consensus estimate of $(0.90) by 6.67%. This represents a 36.84% increase over losses from the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 08, 2023 | 8:02 pm

LAZR

Luminar Technologies reported Q2 adjusted EPS of $(0.21), beating the estimate of $(0.23) by 8.7%. The company's quarterly sales were $16.20 million, surpassing the estimate of $16.18 million by 0.11%. However, the EPS represents a 16.67% decrease from the same period last year, while the sales show a 63.08% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:02 pm

IRBT

iRobot reported Q2 losses of $(1.42) per share, beating the analyst consensus estimate of $(1.50) by 5.33 percent. This is a 305.71 percent decrease over losses from the same period last year. The company also reported quarterly sales of $236.60 million, beating the analyst consensus estimate of $227.21 million by 4.13 percent, but a 7.34 percent decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:02 pm

NVAX

Novavax Inc (NVAX) reported Q2 revenue of $424 million, beating the consensus of $257.62 million. The company is on track with its global restructuring and cost reduction plan, targeting to reduce annual combined R&D and SG&A expenses by 20%-25% in 2023 and 40%-50% in 2024. Novavax reported an EPS income of $0.58, a turnaround from an EPS loss of $(6.53) a year ago. However, the company lowered its FY23 revenue guidance to $1.3-$1.5 billion. Novavax also executed a new strategic partnering agreement with SK Bioscience.

Portfolio Pulse from Vandana Singh

August 08, 2023 | 8:02 pm

SDC

SmileDirectClub (NASDAQ:SDC) reported Q2 losses of $(0.13) per share, missing the analyst consensus estimate of $(0.11) by 18.18%. The company also reported quarterly sales of $101.80 million, missing the estimate of $101.91 million by 0.11%. This represents a 23.53% increase in losses and a 19.08% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:02 pm

CPNG

Coupang (NYSE:CPNG) reported Q2 earnings of $0.08 per share, beating the analyst consensus estimate of $0.06 by 33.33%. This is a 300% increase over losses from the same period last year. The company also reported quarterly sales of $5.84 billion, beating the analyst consensus estimate of $5.81 billion by 0.55%. This is a 15.88% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:01 pm